0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine

Buy Now

Adalat - A Comprehensive Review (Paperback, Softcover reprint of the original 1st ed. 1991) Loot Price: R2,778
Discovery Miles 27 780
Adalat - A Comprehensive Review (Paperback, Softcover reprint of the original 1st ed. 1991): P.R. Lichtlen, A Reale

Adalat - A Comprehensive Review (Paperback, Softcover reprint of the original 1st ed. 1991)

P.R. Lichtlen, A Reale

 (sign in to rate)
Loot Price R2,778 Discovery Miles 27 780 | Repayment Terms: R260 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

As little as 30 years ago, cardiovascular research at Bayer was just a small sideline with in an environment dominated by chemotherapy research, and only 15 years ago, Bayer's pharmaceutical business was confined to European and Latin Ameri can countries, with sales in cardiovascular pharmaceuticals close to zero. It goes without saying that Adalat has changed the company as a whole in its research, development, and marketing, both in Germany and, most importantly, world wide. In research and development, Adalat has led the way in to new areas such as hypertension, acute neurology, dementia, atherosclerosis, and heart failure. In pharmacology, Adalat was present at the dawning of the second phar macological revolution, which started out from whole animal models and progres sed, via in vitro screening and pharmacological research on the DHP receptor, down to the molecular level with the cloning of calcium-channel proteins. Having followed the Adalat story closely in its early years as a bench scientist, let me take this opportunity to thank the inventors, the scientists, and the investigators who have helped to tap the broad potential of calcium-channel blockade with dihyd ropyridines in general and Adalat in particular. But, success should not obscure our vision. There is no reason for us to rest on our laurels: it will take true innovations in cardiovascular research to top the gold standard set by Adalat. Let us take up the challenge.

General

Imprint: Springer-Verlag
Country of origin: Germany
Release date: July 2012
First published: 1991
Editors: P.R. Lichtlen • A Reale
Dimensions: 235 x 155 x 14mm (L x W x T)
Format: Paperback
Pages: 237
Edition: Softcover reprint of the original 1st ed. 1991
ISBN-13: 978-3-642-85500-9
Categories: Books > Medicine > Clinical & internal medicine > General
Books > Medicine > Other branches of medicine > Pharmacology > General
LSN: 3-642-85500-8
Barcode: 9783642855009

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners